切换至 "中华医学电子期刊资源库"

中华肾病研究电子杂志 ›› 2015, Vol. 04 ›› Issue (02) : 82 -86. doi: 10.3877/cma.j.issn.2095-3216.2015.02.006

所属专题: 文献

专家论坛

反流性肾病的中西医诊治现状
刘华锋1,(), 安宁1, 刘伟敬1   
  1. 1. 524001 广东省湛江市,广东医学院附属医院肾病研究所
  • 出版日期:2015-04-28
  • 通信作者: 刘华锋

Current diagnosis and treatment of reflux nephropathy with integrated traditional Chinese and western medicine

Huafeng Liu1,(), Ning An1, Weijing Liu1   

  1. 1. Institute of Nephrology, Guangdong Medical College Affiliated Hospital, Zhanjiang 524001, Guangdong Province, China
  • Published:2015-04-28
  • Corresponding author: Huafeng Liu
  • About author:
    Corresponding author: Liu Huafeng, Email:
引用本文:

刘华锋, 安宁, 刘伟敬. 反流性肾病的中西医诊治现状[J]. 中华肾病研究电子杂志, 2015, 04(02): 82-86.

Huafeng Liu, Ning An, Weijing Liu. Current diagnosis and treatment of reflux nephropathy with integrated traditional Chinese and western medicine[J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2015, 04(02): 82-86.

反流性肾病(RN)是指由于膀胱输尿管反流(VUR)和肾内反流(IRR)伴反复尿路感染,导致肾脏形成瘢痕、萎缩、肾功能异常的一类临床综合征。RN是造成ESRD的原因之一。RN最基本的病理特点是肾脏瘢痕形成。常见的临床表现有持续或反复发作的尿路感染、蛋白尿、高血压、夜尿、多尿、腰痛、尿路结石等。治疗上主要包括西医保守治疗、外科治疗及中医治疗。西医保守治疗主要采用抗感染和综合对症治疗措施,以预防和延缓肾实质损害和肾功能减退。外科手术治疗为传统抗反流手术和内镜下注射治疗。RN中医学属"淋证"、"尿频"、"腰痛"、"遗尿"及"癃闭"等疾病范畴。基本病机为本虚标实,虚实错杂,早期以标实为主,后期以本虚为甚,需辩证施治。

Reflux nephropathy (RN) is a kind of clinical syndrome characterized by kidney scarring, atrophy, and renal dysfunction due to vesicoureteral reflux (VUR) and intrarenal reflux (IRR) with recurrent urinary tract infections. RN is one of the important causes of end-stage renal diseases (ESRD), and its basic pathological feature is renal scarring, with common clinical manifestations of continuous or recurrent urinary tract infections, proteinuria, hypertension, nocturia, polyuria, lower back pain, urinary calculi, and so on. The treatment consists of conservative therapy, surgical therapy, and traditional Chinese medicine (TCM) therapy. In western medicine conservative therapy, mainly anti-infection and comprehensive symptomatic treatment are performed in order to prevent or delay renal parenchyma damage and kidney dysfunction, while surgical treatment includes traditional anti-reflux surgery and endoscopic injection therapy. RN in TCM refers to disease categories of "gonorrhea" , "frequent urination" , "osphyalgia" , "nocturnal enuresis" , and "uroschesis" , with a basic pathogenesis comprised of deficiency in origin and excess in superficiality, mixture of deficiency and excess, and early domination of excess in superficiality while later domination of deficiency in origin, which demands treatment with syndrome differentiation.

[1]
Bailey RR. The relationship of vesico-ureteric reflux to urinary tract infection and chronic pyelonephritis-reflux nephropathy [J]. Clin Nephrol, 1973, 1(3): 132-141.
[2]
Fillion ML, Watt CL, Gupta IR. Vesicoureteric reflux and reflux nephropathy: from mouse models to childhood disease [J]. Pediatr Nephrol, 2014, 29(4): 757-766.
[3]
Canadian Institute for Health Information. Canadian Organ Replacement Register Annual Report: Treatment of End-Stage Organ Failure in Canada, 2000 to 2009 [M]. Ottawa: Canadian Institute for Health Information, 2011: 47.
[4]
North American Pediatric Renal Trials and Collaborative Studies: NAPRTS annual report [EB/OL] 2011.

URL    
[5]
Edwards D, Normand IC, Prescod N, et al. Disappearance of vesicoureteric reflux during long-term prophylaxis of urinary tract infection in children [J]. Br Med J, 1977, 2(6082): 285-288.
[6]
Roberts JA. Vesicoureteral reflux and pyelonephritis in the monkey: a review [J]. J Urol, 1992, 148(5 Pt 2): 1721-1725.
[7]
Ransley PG, Risdon RA. Renal papillary morphology and intrarenal reflux in the young pig [J]. Urol Res, 1975, 3(3): 105-109.
[8]
Hodson CJ. Reflux nephropathy: A personal historical review [J]. Am J Roentgenol, 1981, 137(3): 451-462.
[9]
Johnston JH. The significance of intrarenal reflux[M]// Johnston JH. Management of vesieoureteric reflux. Baltirnore: Wiliams and Wilkins, 1984: 36-39.
[10]
Ragnarsdóttir B, Lutay N, Grönberg-Hernandez J, et al. Genetics of innate immunity and UTI susceptibility [J]. Nat Rev Urol, 2011, 8(8): 449-468.
[11]
Androulakakis PA, Ransly PG, Risdon PA, et al. Microvaseular changes in the early stage of reflux pyelonephritis [J]. Eur Urol, 1987, 13(4): 219-223.
[12]
Cendron M. Reflux nephropathy [J]. J Pediatr Urol, 2008, 4(6): 414-421.
[13]
王海燕. 肾脏病学[M]. 第3版. 北京:人民卫生出版社,2008: 1286-1291.
[14]
RIVUR Trial Investigators, Hoberman A, Greenfield SP, et al. Antimicrobial prophylaxis for children with vesicoureteral reflux [J]. N Engl J Med, 2014, 370(25): 2367-2376.
[15]
Yavuz S, Anarat A, Bayazt AK. Interleukin-18, CRP and procalcitonin levels in vesicoureteral reflux and reflux nephropathy [J]. Ren Fail, 2013, 35(10): 1319-1322.
[16]
Dillon MJ, Goonasekera CD. Reflux nephropathy [J]. J Am Soc Nephrol, 1998, 9(12): 2377-2383.
[17]
Jungers P, Houillier P, Chauveau D, et al. Pregnancy in women with reflux nephropathy [J]. Kidney Int, 1996, 50(2): 593-599.
[18]
李幼姬,黄锋先. 成人膀胱输尿管反流及反流性肾病的临床研究 [J]. 中华肾脏病杂志,1991, 7(6): 341-344.
[19]
Slabbaert K, Bogaert G. Vesicoureteric reflux (VUR) in children: where are we now [J]. Arch Esp Urol, 2012, 65(4): 450-458.
[20]
Tse KS, Wong LS, Lau HY, et al. Paediatric vesicoureteric reflux imaging: where are we? Novel ultrasound-based voiding urosonography [J]. Hong Kong Med J, 2014, 20(5): 437-443.
[21]
Westwood ME, Whiting PF, Cooper J, et al. Further investigation of confirmed urinary tract infection (UTI) in children under five years: a systematic review [J]. BMC Pediatr, 2005, 5(1): 2.
[22]
El-Khatib MT, Becker GJ, Kincaid-Smith PS. Morphometric aspects of reflux nephropathy [J]. Kidney Int, 1987, 32(2): 261-266.
[23]
Wong IY, Copp HL, Clark CJ, et al. Quantitative ultrasound renal parenchymal area correlates with renal volume and identifies reflux nephropathy [J]. J Urol, 2009, 182(4 Suppl): 1683-1687.
[24]
Kincaid-Smith PS. Diffuse parenchymal lesions in reflux nephropathy and the possibility of making a renal biopsy diagnosis in reflux nephropathy [J]. Contrib Nephrol, 1984, 39: 111-115.
[25]
Lavocat MP, Granjon D, Allard D, et al. Imaging of pyelonephritis [J]. Pediatr Radiol, 1997, 27(2): 159-165.
[26]
Brakeman P. Vesicoureteral reflux, reflux nephropathy, and end-stage renal disease [J]. Adv Urol, 2008, 2008: 508949.
[27]
Tekgül S1, Riedmiller H, Hoebeke P, et al. EAU guidelines on vesicoureteral reflux in children [J]. Eur Urol, 2012, 62(3): 534-542.
[28]
Leclair MD, Héloury Y. Non-neurogenic elimination disorders in children [J]. J Pediatr Urol, 2010, 6(4): 338-345.
[29]
Peters CA, Skoog SJ, Arant BS Jr, et al. Summary of the AUA Guideline on Management of Primary Vesicoureteral Reflux in Children [J]. J Urol, 2010, 184(3): 1134-1144.
[30]
Sung J, Skoog S. Surgical management of vesicoureteral reflux in children [J]. Pediatr Nephrol, 2012, 27(4): 551-561.
[31]
王钢,陈以平,邹燕勤. 现代中医肾脏病学[M]. 北京:人民卫生出版社,2003:799-809.
[32]
范萍,吕宏生. 吕承全治疗返流性肾病经验 [J]. 河南中医药学刊,2000, 15(5): 6-7.
[1] 杨水华, 何桂丹, 覃桂灿, 梁蒙凤, 罗艳合, 李雪芹, 唐娟松. 胎儿孤立性完全型肺静脉异位引流的超声心动图特征及高分辨率血流联合时间-空间相关成像的应用[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1061-1067.
[2] 中华医学会骨科学分会关节外科学组, 广东省医学会骨质疏松和骨矿盐疾病分会, 广东省佛山市顺德区第三人民医院. 中国髋部脆性骨折术后抗骨质疏松药物临床干预指南(2023年版)[J]. 中华关节外科杂志(电子版), 2023, 17(06): 751-764.
[3] 许正文, 李振, 侯振扬, 苏长征, 朱彪. 富血小板血浆联合植骨治疗早期非创伤性股骨头坏死[J]. 中华关节外科杂志(电子版), 2023, 17(06): 773-779.
[4] 李培杰, 乔永杰, 张浩强, 曾健康, 谭飞, 李嘉欢, 王静, 周胜虎. 细菌培养阴性的假体周围感染诊治的最新进展[J]. 中华关节外科杂志(电子版), 2023, 17(06): 827-833.
[5] 王得晨, 杨康, 杨自杰, 归明彬, 屈莲平, 张小凤, 高峰. 结直肠癌微卫星稳定状态和程序性死亡、吲哚胺2,3-双加氧酶关系的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(06): 462-465.
[6] 彭旭, 邵永孚, 李铎, 邹瑞, 邢贞明. 结肠肝曲癌的诊断和外科治疗[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 108-110.
[7] 马伟强, 马斌林, 吴中语, 张莹. microRNA在三阴性乳腺癌进展中发挥的作用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 111-114.
[8] 蓝冰, 王怀明, 王辉, 马波. 局部晚期结肠癌膀胱浸润的研究进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 505-511.
[9] 杨红杰, 张智春, 孙轶. 直肠癌淋巴结转移诊断研究进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 512-518.
[10] 袁媛, 赵良平, 刘智慧, 张丽萍, 谭丽梅, 閤梦琴. 子宫内膜癌组织中miR-25-3p、PTEN的表达及与病理参数的关系[J]. 中华临床医师杂志(电子版), 2023, 17(9): 1016-1020.
[11] 陆志峰, 周佳佳, 梁舒. 虚拟现实技术在治疗弱视中的临床应用研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(08): 891-895.
[12] 李田, 徐洪, 刘和亮. 尘肺病的相关研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(08): 900-905.
[13] 岳瑞雪, 孔令欣, 郝鑫, 杨进强, 韩猛, 崔国忠, 王建军, 张志生, 孔凡庭, 张维, 何文博, 李现桥, 周新平, 徐东宏, 胡崇珠. 乳腺癌HER2蛋白表达水平预测新辅助治疗疗效的真实世界研究[J]. 中华临床医师杂志(电子版), 2023, 17(07): 765-770.
[14] 周婷, 孙培培, 张二明, 安欣华, 向平超. 北京市石景山区40岁及以上居民慢性阻塞性肺疾病诊断现状调查[J]. 中华临床医师杂志(电子版), 2023, 17(07): 790-797.
[15] 符梅沙, 周玉华, 李慧, 薛春颜. 淋巴细胞免疫治疗对复发性流产患者外周血T淋巴细胞亚群分布与PD1/PD-L1表达的影响及意义[J]. 中华临床医师杂志(电子版), 2023, 17(06): 726-730.
阅读次数
全文


摘要